Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007.

A capacitive read only memory operable to respond to the logical product of the inputs to the memory. The read only memory consists of a pair of plates or memory planes capacitively coupled together. Circuitry logically inverts the input pulses to the first plane and selective capacitor placement creates pulsing on all outputs from the second plane except on the desired output. Circuitry logically inverts the pulses from the second plane resulting in an output which is the logical product of the input signals.

[1]  A. Criego,et al.  Eating Disorders and Diabetes , 2009, Diabetes Spectrum.

[2]  Eve Roelker,et al.  Screening for Coronary Artery Disease in Patients With Diabetes , 2008 .

[3]  R. Rubin,et al.  Behavioral and Psychosocial Interventions in Diabetes , 2007, Diabetes Care.

[4]  Yoon K Loke,et al.  Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. , 2007, JAMA.

[5]  Inder Singh,et al.  High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.

[6]  P. Mehler,et al.  Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial , 2007, Nature Clinical Practice Nephrology.

[7]  J. Krinsley Glycemic control in critically ill patients: Leuven and beyond. , 2007, Chest.

[8]  Dana Dabelea,et al.  Incidence of diabetes in youth in the United States. , 2007, JAMA.

[9]  K. Wolski,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[10]  Susan Smyth,et al.  Aspirin dose for the prevention of cardiovascular disease: a systematic review. , 2007, JAMA.

[11]  Rajiv Raman,et al.  The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.

[12]  K. Reinhart,et al.  Intensive insulin therapy in the ICU: benefit versus harm? , 2007, Intensive Care Medicine.

[13]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[14]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[15]  H. Gerstein Point: If It Is Important to Prevent Type 2 Diabetes, It Is Important to Consider All Proven Therapies Within a Comprehensive Approach , 2007, Diabetes Care.

[16]  J. Bosch,et al.  Association of diabetes‐related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[17]  P. Cryer Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2007, Diabetes Care.

[18]  Kathleen N Lohr,et al.  Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations , 2006, Annals of Internal Medicine.

[19]  R. Radermecker Intensive Insulin Therapy in the Intensive Care Unit: Assessment by Continuous Glucose Monitoring , 2006, Diabetes Care.

[20]  M. Molitch,et al.  Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[21]  D. Mikhailidis,et al.  Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) , 2006, Diabetes Care.

[22]  B. Davis,et al.  Abstract 2734: Heart Failure with Preserved and Impaired Left Ventricular Systolic Function in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2006 .

[23]  Rodney A Hayward,et al.  Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem , 2006, Annals of Internal Medicine.

[24]  Desmond E. Williams,et al.  The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.

[25]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[26]  C. Apovian,et al.  Nutrition Recommendations and Interventions for Diabetes–2006 , 2006, Diabetes Care.

[27]  S. Braithwaite,et al.  Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. , 2006, The American journal of cardiology.

[28]  K. Shojania,et al.  Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. , 2006, JAMA.

[29]  A. Mooradian,et al.  Narrative Review: A Rational Approach to Starting Insulin Therapy , 2006, Annals of Internal Medicine.

[30]  S. Hernández-Díaz,et al.  Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.

[31]  M. Phillip,et al.  Insulin Pump Therapy in Youth With Type 1 Diabetes: A Retrospective Paired Study , 2006, Pediatrics.

[32]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[33]  T. Horsley,et al.  Effectiveness of community health workers in the care of persons with diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[34]  G. Remuzzi,et al.  Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. , 2006, Journal of the American Society of Nephrology : JASN.

[35]  M. Mclean,et al.  The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.

[36]  M. Briel,et al.  Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[37]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[38]  J. Albers,et al.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.

[39]  C. Snehalatha,et al.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.

[40]  A. Avogaro,et al.  Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. , 2006, Journal of the American College of Cardiology.

[41]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[42]  P Glasziou,et al.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.

[43]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[44]  R. Collins,et al.  Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). , 2005, Diabetes care.

[45]  Jay R. Desai,et al.  Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. , 2005, Diabetes care.

[46]  J. Mahoney Reducing patient drug acquisition costs can lower diabetes health claims. , 2005, The American journal of managed care.

[47]  Patrick J O'Connor,et al.  Factors driving diabetes care improvement in a large medical group: ten years of progress. , 2005, The American journal of managed care.

[48]  H. Kramer,et al.  Screening for kidney disease in adults with diabetes. , 2005, Diabetes care.

[49]  L. Bouter,et al.  Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.

[50]  M. C. Leske,et al.  Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. , 2005, Ophthalmology.

[51]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[52]  R. Freeman,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[53]  J Herlitz,et al.  Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.

[54]  J. Rosenstock,et al.  Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. , 2005, Diabetes care.

[55]  W. Herman,et al.  The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.

[56]  Jonathan J Shuster,et al.  Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. , 2004, Diabetes care.

[57]  J. Lau,et al.  Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. , 2004, Archives of internal medicine.

[58]  K. Borch-Johnsen,et al.  Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .

[59]  F. Kaufman,et al.  Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. , 2004, The Journal of pediatrics.

[60]  Carmen Castaneda-Sceppa,et al.  Physical activity/exercise and type 2 diabetes. , 2004, Diabetes care.

[61]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[62]  M. Pfeffer,et al.  Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.

[63]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[64]  Daniel H Solomon,et al.  Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. , 2004, Archives of internal medicine.

[65]  Judith Wylie-Rosett,et al.  Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. , 2004, Diabetes care.

[66]  E. Barrett,et al.  Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.

[67]  C. Schmid,et al.  Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. , 2004, Archives of internal medicine.

[68]  W. Tamborlane,et al.  A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. , 2004, Diabetes care.

[69]  R. Misbin The phantom of lactic acidosis due to metformin in patients with diabetes. , 2004, Diabetes care.

[70]  Mark R Conaway,et al.  Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. , 2004, Diabetes care.

[71]  M. Rewers,et al.  Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.

[72]  P. Cryer Diverse causes of hypoglycemia-associated autonomic failure in diabetes. , 2004, The New England journal of medicine.

[73]  E. Gracely,et al.  The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial , 2004, Annals of Internal Medicine.

[74]  Prakash L Mokshagundam Perioperative Management of Diabetes Mellitus , 2004, Critical care nursing quarterly.

[75]  Gilles Chatellier,et al.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.

[76]  Paul Schoenhagen,et al.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.

[77]  M. Rewers,et al.  Celiac disease associated with type 1 diabetes mellitus. , 2004, Endocrinology and metabolism clinics of North America.

[78]  M. Porta,et al.  A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. , 2004, Diabetes care.

[79]  Irl B Hirsch,et al.  Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.

[80]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[81]  Carl J Pepine,et al.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.

[82]  M. Roncaglioni,et al.  Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. , 2003, Diabetes care.

[83]  E. Salpeter,et al.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. , 2003, Archives of internal medicine.

[84]  Lee Hebert,et al.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[85]  M. Pfeffer,et al.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.

[86]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[87]  M. Pfeffer,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.

[88]  B. Zinman,et al.  Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. , 2003, Diabetes care.

[89]  Stanton Newman,et al.  A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. , 2003, Patient education and counseling.

[90]  Malinda Peeples,et al.  Diabetes Self-Management Education Core Outcomes Measures , 2003, The Diabetes educator.

[91]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[92]  R. Sigal,et al.  Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus , 2003, Diabetologia.

[93]  M. Franz,et al.  How effective is medical nutrition therapy in diabetes care? , 2003, Journal of the American Dietetic Association.

[94]  B. McCrindle,et al.  Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. , 2003, The Journal of pediatrics.

[95]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[96]  D. Rader,et al.  A randomized trial of a low-carbohydrate diet for obesity. , 2003, The New England journal of medicine.

[97]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[98]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[99]  I. Hirsch,et al.  Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.

[100]  E. Guallar,et al.  Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes , 2003, The Diabetes educator.

[101]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[102]  C. Mangione,et al.  Guidelines for improving the care of the older person with diabetes mellitus. , 2003, Journal of the American Geriatrics Society.

[103]  M. Pfeffer,et al.  Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy , 2003, Annals of Internal Medicine.

[104]  Patrick J O'Connor,et al.  Electronic medical records and diabetes care improvement: are we waiting for Godot? , 2003, Diabetes care.

[105]  David M Nathan,et al.  A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. , 2003, Diabetes care.

[106]  M. Cakir,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2003, The Journal of clinical endocrinology and metabolism.

[107]  Russell Harris,et al.  Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[108]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[109]  R. Klein,et al.  Screening interval for retinopathy in type 2 diabetes , 2003, The Lancet.

[110]  Simon P Harding,et al.  Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.

[111]  J. Kastelein,et al.  Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[112]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[113]  C. Castaneda,et al.  A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. , 2002, Diabetes care.

[114]  G. Holmes,et al.  Screening for coeliac disease in type 1 diabetes , 2002, Archives of disease in childhood.

[115]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[116]  N. Levinsky Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.

[117]  Deepak L. Bhatt,et al.  Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.

[118]  A. Ceriello,et al.  Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment , 2002, Circulation.

[119]  K. Freedland,et al.  Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature , 2002, International journal of psychiatry in medicine.

[120]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[121]  S. Grundy,et al.  Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. , 2002, Archives of internal medicine.

[122]  H. Parving,et al.  Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. , 2002, Kidney international.

[123]  C. Schmid,et al.  Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.

[124]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[125]  O. Kordonouri,et al.  Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[126]  P. Cryer,et al.  Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.

[127]  Steven Snapinn,et al.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.

[128]  M. Franz,et al.  The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.

[129]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[130]  G. Bakris,et al.  Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease , 2002, Vascular medicine.

[131]  D. Kendall,et al.  Assessment of group versus individual diabetes education: a randomized study. , 2002, Diabetes care.

[132]  Terho Lehtimäki,et al.  Carotid artery intima-media thickness in children with type 1 diabetes. , 2002, Diabetes.

[133]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[134]  R. Sigal,et al.  Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.

[135]  U. S. P. S. T. Force,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale , 2002, Annals of Internal Medicine.

[136]  Nina Singh,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[137]  A. Mohn,et al.  The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[138]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[139]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[140]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[141]  C. D. Miller,et al.  Hypoglycemia in patients with type 2 diabetes mellitus. , 2001, Archives of internal medicine.

[142]  J. Cornel,et al.  Impaired glucose metabolism predicts mortality after a myocardial infarction. , 2001, International journal of cardiology.

[143]  N. Hollenberg ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. , 2001, Current hypertension reports.

[144]  L. Kuller,et al.  Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2001, Diabetes care.

[145]  R. Meek,et al.  A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. , 2001, Diabetes care.

[146]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[147]  M Peyrot,et al.  Psychological issues and treatments for people with diabetes. , 2001, Journal of clinical psychology.

[148]  S. Norris,et al.  Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. , 2001, Diabetes care.

[149]  P. Valensi,et al.  Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. , 2001, Diabetes care.

[150]  G. Bakris,et al.  ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. , 2000, Kidney international.

[151]  D. Hunninghake,et al.  Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. , 2000, JAMA.

[152]  G. Bakris,et al.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[153]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[154]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[155]  Diabetes Control Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.

[156]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[157]  Michael A Weiss,et al.  National Standards for Diabetes Self-Management Education , 2000, Diabetes Care.

[158]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[159]  R. Hayward,et al.  Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. , 2000, JAMA.

[160]  Matthew D. Davis,et al.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.

[161]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[162]  K. Jablonski,et al.  Effect of physician specialty on outcomes in diabetic ketoacidosis. , 1999, Diabetes care.

[163]  D. Nathan,et al.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. , 1999, Diabetes care.

[164]  F. Brancati,et al.  Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. , 1999, Diabetes care.

[165]  R. Holl,et al.  Thyroid Autoimmunity in Children and Adolescents with Type 1 Diabetes mellitus , 1999, Hormone Research in Paediatrics.

[166]  Ames,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[167]  A. Donker,et al.  The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[168]  J. Viikari,et al.  Serum cholesterol ester fatty acids in 7‐ and 13‐month‐old children in a prospective randomized trial of a low‐saturated fat, low‐cholesterol diet: the STRIP baby project , 1999, Acta paediatrica.

[169]  D. Schriger,et al.  Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. , 1999, JAMA.

[170]  P. Kris-Etherton,et al.  Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. , 1999, The American journal of clinical nutrition.

[171]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[172]  B. Zinman,et al.  Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. , 1999, Diabetes care.

[173]  G. Grunkemeier,et al.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.

[174]  B. Davis,et al.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.

[175]  G. Reiber,et al.  Preventive Foot Care in People With Diabetes , 1998, Diabetes Care.

[176]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[177]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[178]  B. Metzger,et al.  Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. , 1998, Diabetes care.

[179]  Y. Friedlander,et al.  Hypoglycemia in Hospitalized Nondiabetic Older Patients , 1998, Journal of the American Geriatrics Society.

[180]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[181]  T A Louis,et al.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[182]  R. Schrier,et al.  Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[183]  R. Newton,et al.  The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four‐year follow‐up , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[184]  M. Pahor,et al.  Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.

[185]  J. Pomposelli,et al.  Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[186]  D. Andrewes,et al.  Neuropsychological Complications of IDDM in Children 2 Years After Disease Onset , 1998, Diabetes Care.

[187]  G. A. Fleming,et al.  Lactic acidosis in patients with diabetes treated with metformin. , 1998, The New England journal of medicine.

[188]  P. O S I T I O N S T A T E M E N T Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.

[189]  J. L. Botha,et al.  Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes , 1997, Epidemiology and Infection.

[190]  J. Colwell Aspirin Therapy in Diabetes , 1997, Diabetes Care.

[191]  J. Ivy Role of Exercise Training in the Prevention and Treatment of Insulin Resistance and Non-Insulin-Dependent Diabetes Mellitus , 1997, Sports medicine.

[192]  L. Poretsky,et al.  Effects of an Intervention by a Diabetes Team in Hospitalized Patients With Diabetes , 1997, Diabetes Care.

[193]  K. Malmberg Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[194]  J. Rovet,et al.  Attentional Functioning in Children and Adolescents With IDDM , 1997, Diabetes Care.

[195]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[196]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[197]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[198]  H. Parving,et al.  Population based study of rates of multiple pregnancies in denmark, 1980-94 , 1997, BMJ.

[199]  F. Brancati,et al.  Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. , 1997, Archives of internal medicine.

[200]  B. Psaty,et al.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.

[201]  G. Grunkemeier,et al.  Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.

[202]  T. Sand,et al.  Cognitive function in Type 1 diabetic children with and without episodes of severe hypoglycaemia , 1997, Acta paediatrica.

[203]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[204]  B. Sibai Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.

[205]  T. Buchanan,et al.  Pre-Conception Care of Diabetes, Congenital Malformations, and Spontaneous Abortions , 1996, Diabetes Care.

[206]  M. Lishner,et al.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.

[207]  J. McGill,et al.  The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.

[208]  C. Levetan,et al.  Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. , 1995, The American journal of medicine.

[209]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[210]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[211]  R. Klein Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[212]  J. Duncan,et al.  Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. , 1994, Family practice research journal.

[213]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[214]  B. Zinman,et al.  Exercise in Individuals With IDDM , 1994, Diabetes Care.

[215]  R. Glasgow,et al.  A Systematic Approach to Diabetes Management in the Post-DCCT Era , 1994, Diabetes Care.

[216]  C. Tsalamandris,et al.  Progressive Decline in Renal Function in Diabetic Patients With and Without Albuminuria , 1994, Diabetes.

[217]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[218]  G. Palomaki,et al.  The Impact of Preconception Counseling on Pregnancy Outcomes: The experience of the Maine Diabetes in Pregnancy Program , 1993, Diabetes Care.

[219]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[220]  R. Rubin,et al.  Psychosocial Problems and Interventions in Diabetes: A review of the literature , 1992, Diabetes Care.

[221]  M. Feinglos,et al.  Stress and Diabetes Mellitus , 1992, Diabetes Care.

[222]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[223]  J. Khoury,et al.  Pre‐conception management of insulin‐dependent diabetes: Improvement of pregnancy outcome , 1991, Obstetrics and gynecology.

[224]  M. Vray,et al.  Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies. A comparison between 1971-1977 and 1978-1985 periods in 389 pregnancies. , 1991, Diabete & metabolisme.

[225]  L. Gavin,et al.  Preconception care of diabetes. Glycemic control prevents congenital anomalies. , 1991, JAMA.

[226]  J. Miller,et al.  Assessing family sharing of diabetes responsibilities. , 1990, Journal of pediatric psychology.

[227]  H. Chase,et al.  Thyroid Hormone Replacement and Growth of Children with Subclinical Hypothyroidism and Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[228]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[229]  J. Stamler,et al.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.

[230]  P. Cryer,et al.  Psychiatric Illness in Diabetes Mellitus: Relationship to Symptoms and Glucose Control , 1986, The Journal of nervous and mental disease.

[231]  J. Newman,et al.  Hypoglycemia in hospitalized patients. Causes and outcomes. , 1986, The New England journal of medicine.

[232]  M. Karp,et al.  Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. , 1986, American journal of obstetrics and gynecology.

[233]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[234]  W. A. Müller,et al.  Metabolic and hormonal effects of muscular exercise in juvenile type diabetics , 1977, Diabetologia.

[235]  W. Howard Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .

[236]  L. Kennedy,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .

[237]  J. Leahy Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .

[238]  J. Boucher,et al.  Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. , 2007, Journal of the American Dietetic Association.

[239]  B. Sears Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. , 2007, MedGenMed : Medscape general medicine.

[240]  R. Eckel,et al.  Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes , 2007 .

[241]  Diabetes care in the school and day care setting. , 2007, Diabetes care.

[242]  M. Roizen Intensive Insulin Therapy in the Medical ICU , 2007 .

[243]  R. Bergenstal Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[244]  L. Blonde,et al.  The Hurricane Katrina aftermath and its impact on diabetes care: observations from "ground zero": lessons in disaster preparedness of people with diabetes. , 2006, Diabetes care.

[245]  L. Siminerio Implementing diabetes self-management training programs: breaking through the barriers in primary care. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[246]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[247]  W. Frishman Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial , 2006 .

[248]  M. Davidson,et al.  Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. , 2005, The American journal of cardiology.

[249]  C. Schmid,et al.  Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. , 2005, American journal of preventive medicine.

[250]  A. Gotto Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. , 2005, The Journal of pediatrics.

[251]  I. Hirsch,et al.  American College of Endocrinology position statement on inpatient diabetes and metabolic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[252]  Theodore Speroff,et al.  Diabetes patient education: a meta-analysis and meta-regression. , 2004, Patient education and counseling.

[253]  S. Grundy,et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. , 2004, Journal of the American College of Cardiology.

[254]  Michael Miller Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[255]  J. Klein,et al.  Screening for type 2 diabetes mellitus in adults: recommendations and rationale. , 2003, Annals of internal medicine.

[256]  Pd redaction Screening for type 2 diabetes. , 2003, Diabetes care.

[257]  Philip Raskin,et al.  The treatment of hypertension in adult patients with diabetes. , 2002, Diabetes care.

[258]  Arshag D Mooradian,et al.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.

[259]  S. Braithwaite,et al.  Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[260]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[261]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[262]  Lead Visual Information Specialist , 2001 .

[263]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[264]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[265]  Illiam,et al.  THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .

[266]  Steven A. Smith,et al.  Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.

[267]  Usdhhs Physical Activity and Health: A Report of the Surgeon General , 1996 .

[268]  Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. , 1995, JAMA.

[269]  Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. , 1995, Kidney international.

[270]  A. Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[271]  Hypoglycemia in hospitalized patients. , 1987, The New England journal of medicine.

[272]  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.

[273]  Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .

[274]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .